Item 2.05. Costs Associated with Exit or Disposal Activities. On March 11, 2026, Atlassian Corporation (the “Company” or “ Atlassian ”) announced a restructuring that results in the elimination of certain roles, impacting approximately 10% of the Company’s workforce. These actions are intended to rebalance the Company to accelerate building the future of teamwork in the AI era. This includes self-funding further investment in key strategic priorities, such as AI and enterprise sales, reorganizing its teams to move with more focus and speed across the Atlassian System of Work, and optimizing for long-term operational efficiency and sustainability. Position eliminations in each country are subject to local law and consultation requirements. The Company estimates it will incur approximately $225 million to $236 million in charges in connection with these actions, of which approximately $169 million to $174 million is expected to result in future cash outlays related to severance, notice period, employee transition and benefits payments and approximately $56 million to $62 million is expected to consist of exit charges associated with office space reductions. The Company intends to exclude the charges associated with these actions from its non-GAAP financial measures. The Company expects the majority of these charges will be incurred in the third quarter of fiscal year 2026 and the execution of these actions, including cash payments, will be substantially complete by the end of the fourth quarter of fiscal year 2026, subject to local law and consultation requirements. The charges the Company expects to incur, and the timing thereof, are subject to a number of assumptions, and actual expenses may differ materially from the estimates disclosed above. In addition, the Company may incur other charges or cash expenditures not currently contemplated due to unanticipated events that may occur, including in connection with the implementation of these actions.
TEAM Atlassian Corp - 8-K
Accession
0001650372-26-0000212.055.027.019.01
Item 2.05 - Costs Associated with Exit or Disposal Activities
299 words
Item 5.02 - Departure/Election of Directors or Certain Officers
96 words
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. As part of its restructuring and reorganization, on March 11, 2026, the Company announced that Rajeev Rajan will step down from the role of Chief Technology Officer (“CTO”), effective March 31, 2026, after almost four years with the Company. Atlassian is thankful for Mr. Rajan’s many contributions in building a world-class R&D organization and congratulates the promotion of next generation AI talent in Taroon Mandhana (CTO Teamwork) and Vikram Rao (CTO Enterprise and Chief Trust Officer).
Item 7.01 - Regulation FD Disclosure
402 words
Item 7.01. Regulation FD Disclosure. An update to Atlassian’s employees from Atlassian’s Chief Executive Officer regarding these actions is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated by reference. Financial Guidance The Company reaffirms its financial guidance for the third quarter of fiscal year 2026, ending March 31, 2026 and for the fiscal year ending June 30, 2026, as provided in the Company’s earnings release that was previously furnished as Exhibit 99.1 to the Company’s Current Report on Form 8-K, as filed with the Securities and Exchange Commission (“SEC”) on February 5, 2026. The information in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. Forward Looking Statements This Current Report on Form 8-K and the accompanying exhibit contain forward-looking statements including, but not limited to, statements related to the expected benefits and impact of the rebalancing of resources, growth opportunities, financial performance, operational efficiency and reinvestment. These forward-looking statements are based only on currently available information and the Company’s current beliefs, expectations, and assumptions. Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties, assumptions, and changes in circumstances that are difficult to predict and many of which are outside of the Company’s control. If the risks materialize, assumptions prove incorrect, or the Company experiences unexpected changes in circumstances, actual results could differ materially from the results implied by these forward-looking statements, and therefore you should not place undue reliance on any forward-looking statements. Risks include, but are not limited to, risks described in the Company’s filings with the SEC, including the Company’s Form 10-Q for the fiscal quarter ended December 31, 2025 and in other filings the Company makes with the SEC from time to time, which could cause actual results to vary from expectations. All forward-looking statements contained herein speak only as of the date hereof. The Company assumes no obligation and does not intend to update these forward-looking statements, except as required by law.
Item 9.01 - Financial Statements and Exhibits
32 words
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 CEO Update March 2026: An important update on our team 104 Cover Page Interactive Data File (formatted as Inline XBRL).